Dalibor Ondruš, Martina Cuninková
Testicular cancer is the most common malignancy in 20-40-year-old men. Numerous literary data have shown an increase in the incidence of testis cancer in the last 40 years with substantial differences among countries. Testicular cancer remains a major success story in the realm of solid tumors. There are still many remaining challenges in diagnosis, treatment, and prevention of long-term toxicity. Multidisciplinary approach (surgical and and platinum-based chemotherapy), however, still encompass the main treatment modalities. Attempts to limit toxicity from both surgery and chemotherapy remain at the forefront of research.